Global Cancer/Tumor Profiling Market Size By Technology (Sequencing Technique, Next-Generation Sequencing (NGS)), By Technique (Genomics, Metabolomics, Proteomics), By Application (Personalized Cancer Medicine, Oncological Diagnostics), By Geographic Scope And Forecast

45783.91
Present Value (M$)
2020
168625.6
Forecast Value (M$)
2028
17.72%
CAGR (%)

Cancer/Tumor Profiling Market size was valued at USD 45783.91 Million in 2020 and is projected to reach USD 168625.6 Million by 2028, growing at a CAGR of 17.72% from 2021 to 2028.

Main companies

  • Qiagen N.V.
  • Illumina Inc.
  • Neogenomics Inc.
  • HTG Molecular Diagnostics
  • Inc.
  • Genomic Health
  • Helomics Corporation
  • Caris Life Sciences
  • Nanostring Technologies
  • Oxford Gene Technology
  • Ribomed Biotechnologies Inc.